UBS Group’s Livent Corporation LTHM Stock Holding History

UBS Group’s Portfolio LTHM Stock Details LTHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-52,300	Closed	-$940K	–	10438
2023 Q4	$940K	Hold	52,300	–	–	﹤0.01%	4555
2023 Q3	$963K	Buy	52,300 +6,000	+13%	+$137K	﹤0.01%	4105
2023 Q2	$1.27M	Buy	+46,300	New	+$1.11M	﹤0.01%	4005
2020 Q2	–	Sell	-2,000,000	Closed	-$10.5M	–	8483
2020 Q1	$10.5M	Hold	2,000,000	–	–	﹤0.01%	1375
2019 Q4	$17.1M	Buy	+2,000,000	New	+$15.3M	0.01%	1488

Other funds holding LTHM

MIM

MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

MLICM

Metropolitan Life Insurance Company (MetLife) New York $328M AUM 9.77% 1-Year Est. Return

AAG

Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

ACA

American Capital Advisory Ketchum, Idaho $248M AUM 21.64% 1-Year Est. Return

UBS Group's LTHM Position: Q1 2024 in Review

UBS Group sold out of Livent Corporation (LTHM) in Q1 2024, closing a stake of 54,181 shares — an estimated $974K sold.

UBS Group first reported a position in LTHM in Q4 2018 and held it in 21 quarters. The position peaked at $11.3M in Q4 2022. 6 funds tracked by Wall St. Rank hold LTHM as of Q1 2024.

UBS Group reported no remaining Livent Corporation position as of Q1 2024 after selling out during the quarter.
UBS Group sold 54,181 Livent Corporation shares in Q1 2024, an estimated $974K.
UBS Group first reported a position in Livent Corporation in Q4 2018 and held it in 21 quarters.
UBS Group's Livent Corporation position peaked at $11.3M in Q4 2022.
6 funds tracked by Wall St. Rank held Livent Corporation as of Q1 2024.

Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.